Phibro Animal Health (NASDAQ:PAHC) Stock Price Expected to Rise, Barclays Analyst Says

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) had its target price raised by investment analysts at Barclays from $13.00 to $20.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an "underweight" rating on the stock. Barclays's target price points to a potential downside of 20.19% from the company's current price.

A number of other analysts have also recently weighed in on the company. Bank of America boosted their price target on Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a research report on Friday, August 30th. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $16.50.

Phibro Animal Health Stock Down 1.9 %

Shares of Phibro Animal Health stock traded down $0.49 on Tuesday, hitting $25.06. 314,254 shares of the company traded hands, compared to its average volume of 157,197. Phibro Animal Health has a 12-month low of $9.40 and a 12-month high of $25.98. The company has a quick ratio of 1.64, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The company has a market cap of $1.01 billion, a PE ratio of 59.35, a PEG ratio of 0.58 and a beta of 0.51. The company has a 50-day moving average price of $22.46 and a 200 day moving average price of $19.52.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.34 by $0.07. The firm had revenue of $273.16 million for the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. Sell-side analysts predict that Phibro Animal Health will post 1.63 earnings per share for the current year.

Insider Buying and Selling at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the stock in a transaction on Wednesday, September 4th. The shares were purchased at an average price of $20.02 per share, with a total value of $100,100.00. Following the acquisition, the director now directly owns 25,000 shares of the company's stock, valued at $500,500. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 50.07% of the company's stock.

Hedge Funds Weigh In On Phibro Animal Health

A number of hedge funds have recently modified their holdings of the stock. CWM LLC raised its holdings in shares of Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company's stock valued at $37,000 after buying an additional 1,035 shares during the last quarter. nVerses Capital LLC bought a new position in Phibro Animal Health in the 3rd quarter worth approximately $70,000. Summit Securities Group LLC acquired a new position in Phibro Animal Health during the 2nd quarter worth $83,000. China Universal Asset Management Co. Ltd. lifted its holdings in Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock worth $88,000 after buying an additional 1,522 shares in the last quarter. Finally, Illinois Municipal Retirement Fund boosted its position in Phibro Animal Health by 7.2% in the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company's stock valued at $148,000 after buying an additional 765 shares during the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.